Publication | Closed Access

Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease

Neurodegenerative DiseasesAlzheimer's DiseaseWeight LossMedicineDegenerative DiseaseNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceNeurodegenerationPharmacologyBehavioral Impairment